a
a
HomeTrading NewsBMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock

BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock

A person walks past the Pfizer Headquarters building in New York, December 7, 2020.

Carlo Allegri | Reuters

The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.

No comments

leave a comment